Brief Online Cognitive Behavioral Therapy for Indian Expatriates with Excessive Worry: a Pilot Feasibility Study
Worry-exp
Pilot Study Testing an Online-delivered Psychological Intervention for Indian Expatriates in Sweden Who Experience Dysfunctional Worry
2 other identifiers
interventional
24
1 country
1
Brief Summary
Background: Expatriates may face challenges through distance from support systems, cultural adjustments, and language barriers, which may be associated with anxiety and elevated worry, particularly in times of ongoing global crises. Brief online cognitive-behavioral therapy (ICBT) is effective for treating excessive worry but has not been adapted for expatriate communities in Sweden.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 15, 2022
CompletedFirst Submitted
Initial submission to the registry
September 22, 2024
CompletedFirst Posted
Study publicly available on registry
September 24, 2024
CompletedSeptember 24, 2024
September 1, 2024
5 months
September 22, 2024
September 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Generalized Anxiety Disorder Scale-7 (GAD-7)
The GAD-7 is a 7-item self-report tool used to assess generalized anxiety disorder severity. It scores symptoms like worry and restlessness over the past two weeks on a scale of 0 to 3, with a total score of 0-21. Scores categorize anxiety as mild, moderate, or severe.
Baseline to post-treatment (5 weeks)
Generalized Anxiety Disorder Scale-7 (GAD-7)
The GAD-7 is a 7-item self-report tool used to assess generalized anxiety disorder severity. It scores symptoms like worry and restlessness over the past two weeks on a scale of 0 to 3, with a total score of 0-21. Scores categorize anxiety as mild, moderate, or severe.
Baseline to 1-month follow-up ( 9 weeks)
Secondary Outcomes (10)
Montgomery Åsberg Depression Rating Scale - Self report (MADRS-S)
Baseline to post-treatment (5 weeks)
Montgomery Åsberg Depression Rating Scale - Self report (MADRS-S)
Baseline to 1-month follow-up ( 9 weeks)
Work and Social Adjustment Scale (WSAS)
Baseline to post-treatment (5 weeks)
Work and Social Adjustment Scale (WSAS)
Baseline to 1-month follow-up ( 9 weeks)
Insomnia Severity Index
Baseline to post-treatment (5 weeks)
- +5 more secondary outcomes
Study Arms (1)
Brief online CBT targeting excessive worry
EXPERIMENTALThe treatment in this trial was based on an online CBT intervention developed by Wahlund et al. (2021) for dysfunctional worry during the COVID-19 pandemic. Originally designed for the Swedish population, the intervention was translated to English and adapted for Indian expatriates in Sweden, addressing broader global crises, including military conflicts and climate change.
Interventions
The intervention with a focus on excessive worry lasted five weeks and was delivered through five online modules with therapist support. Modules covered psychoeducation, problem-solving, reducing excessive media consumption, detached mindfulness, and shifting focus from worry. The final module offered relapse prevention strategies.
Eligibility Criteria
You may qualify if:
- identifying as Indian expatriate currently living in Sweden
- self-reported dysfunctional worry, defined as worrying several times a day and the worry being experienced as difficult to control
- age ≥ 18 years;
- able to provide digital informed consent
- having daily access to a device with internet connection.
You may not qualify if:
- non-English speaking
- self-reported severe depression (\>28 points on the Montgomery Åsberg Depression Rating Scale (MADRS-S; (Svanborg \& Åsberg, 1994)
- suicidal risk (5 points on item 9 on the MADRS-S).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Psychiatry Research, Karolinska Institutet, Stockholm Healthcare Services
Stockholm, 17177, Sweden
Related Publications (4)
Uvais NA, Nalakath MJ, Shihabudheen P, Hafi NAB, Salman CA. Depression, Anxiety, and Coping During the COVID-19 Pandemic Among Indian Expats in the Middle East: A Survey Study. Prim Care Companion CNS Disord. 2021 Jan 21;23(1):20m02761. doi: 10.4088/PCC.20m02761.
PMID: 33480484BACKGROUNDVijayakumar, P. B., & Cunningham, C. J. L. (2016). Cross-cultural adjustment and expatriation motives among Indian expatriates. Journal of Global Mobility: The Home of Expatriate Management Research, 4(3), 326-344. https://doi.org/10.1108/jgm-05-2016-0019
BACKGROUNDZhou ES, Ritterband LM, Bethea TN, Robles YP, Heeren TC, Rosenberg L. Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women: A Randomized Clinical Trial. JAMA Psychiatry. 2022 Jun 1;79(6):538-549. doi: 10.1001/jamapsychiatry.2022.0653.
PMID: 35442432BACKGROUNDWahlund T, Mataix-Cols D, Olofsdotter Lauri K, de Schipper E, Ljotsson B, Aspvall K, Andersson E. Brief Online Cognitive Behavioural Intervention for Dysfunctional Worry Related to the COVID-19 Pandemic: A Randomised Controlled Trial. Psychother Psychosom. 2021;90(3):191-199. doi: 10.1159/000512843. Epub 2020 Nov 19.
PMID: 33212440BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Nitya Jayaram-Lindström, PhD
Karolinska Institutet
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, Director of Centre for Psychiatry Research
Study Record Dates
First Submitted
September 22, 2024
First Posted
September 24, 2024
Study Start
June 1, 2022
Primary Completion
October 15, 2022
Study Completion
October 15, 2022
Last Updated
September 24, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
GDPR is not allowing.